𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Associations between polymorphisms in the steroid 5-α reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer☆

✍ Scribed by Muhammad T. Salam; Giske Ursin; Eila C. Skinner; Tesfaye Dessissa; Juergen K.V. Reichardt

Book ID
116955716
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
118 KB
Volume
23
Category
Article
ISSN
1078-1439

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Polymorphic markers in the 5α-reductase
Polymorphic markers in the 5α-reductase type II gene and the incidence of prostate cancer
✍ Najib Lamharzi; Melissa M. Johnson; Gary Goodman; Ruth Etzioni; Noel S. Weiss; D 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 73 KB

## Abstract In the prostate, the enzyme encoded by the __SRD5A2__ gene (5α‐reductase) converts testosterone to dihydrotestosterone, a potent androgen that has been hypothesized to play a role in the genesis of prostate cancer. Several polymorphisms have been identified in the __SRD5A2__ gene, inclu

5α-Reductase type 2 gene variant associa
5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
✍ Vanessa M. Hayes; Gianluca Severi; Emma J.D. Padilla; Howard A. Morris; Wayne D. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 101 KB

## Abstract Controversy exists over the significance of associations between the __SRD5A2__ (5α‐reductase type 2) polymorphisms, A49T and V89L, and risk of prostate cancer. These potentially functional polymorphisms may alter life‐long exposure to androgens with subsequent effects on male health an